SIM
RXII

Spark Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Spark Investment Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-308,500
Closed -$462K – 855
2014
Q4 		$462K Buy
+308,500
New +$462K 0.08% 335

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Spark Investment Management's RXII Position: Q1 2015 in Review

Spark Investment Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2015, closing a stake of 308,500 shares — an estimated $462K sold.

Spark Investment Management first reported a position in RXII in Q4 2014 and held it in 1 quarter. The position peaked at $462K in Q4 2014. 87 funds tracked by Wall St. Rank hold RXII as of Q1 2015.

  • Spark Investment Management reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2015 after selling out during the quarter.
  • Spark Investment Management sold 308,500 GALENA BIOPHARMA INC COM shares in Q1 2015, an estimated $462K.
  • Spark Investment Management first reported a position in GALENA BIOPHARMA INC COM in Q4 2014 and held it in 1 quarter.
  • Spark Investment Management's GALENA BIOPHARMA INC COM position peaked at $462K in Q4 2014.
  • 87 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2015.

Based on Spark Investment Management's 13F filing for Q1 2015, filed 12 May 2015.